Horizon Pharma plc to Participate in Jefferies 2016 Healthcare Conference

DUBLIN, IRELAND--(Marketwired - Jun 2, 2016) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will present at the Jefferies 2016 Healthcare Conference at 2 p.m. EDT on June 9, 2016 in New York City, NY.

The conference presentation, which will include an update of Horizon's business, will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.

About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets nine medicines through its orphan, rheumatology and primary care business units. Horizon Pharma's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contacts:

Investors:
John Thomas
Executive Vice President
Strategy & Investor Relations
[e-mail]

Tina Ventura
Vice President
Investor Relations
[e-mail]

U.S. Media:
Geoff Curtis
Senior Vice President
Corporate Communications
[e-mail]

Ireland Media:
Ray Gordon
Gordon MRM
[e-mail]